Tumores Malignos do Intestino Delgado
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/3214 |
Resumo: | Primary malignant tumours of the small intestine are uncommon and are often diagnosed at na advanced stage. Seventeen cases of malignant tumours of the small intestine were encountered over a 27-year period in the Serviço de Cirurgia from Ribeirão Preto. The ileum was the most common location, with a decreasing frequency proximally. Synchronous tumours were found in 35.29% of the patients. Presenting signs and symptoms were vague and related mainly to abdominal pain (94.12%), nausea and vomiting (52.94%), weight loss (52.94%), and anorexia (35.29%). An abdominal tumour was evident in 35.29910 of patients. Three patients presented with perforation of the tumour, one of them af ter radiotherapy. Barium contrast examination was the primary complementary diagnostic modality. The treatment was wide resection of bowel and mesentery, whenever possible, for jejunal and ileal tumours, together with resection of other involved organs. In one case only biopsy could be perforrned. Lymphoma was the most common malignancy, followed by leiomyosarcoma and adenocarcinoma. The operative mortality was 23.53% (4 patients), 3 from sepsis (two opera ted on with peritonitis) and one from anesthetic problem. Adjuvant radiotherapy and/or chemotherapy was used in the patients who survived surgery except in one. AlI leiomyosarcoma recurred and the patients were opera ted on again with a new resection. Four patients are alive from 2 to 15 years af ter surgery The 5-year survival rate for the lymphomas is 25% (38% if the operative deaths are excluded), and for the adenocarcinoma is 100% (only 2 cases). Whereas the symptoms are vague, the diagnostic of small bowel tumour must be cogitated if the prognosis is to be improved. |
id |
INCA-1_67d7daa21435a427556af9b8976b9108 |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/3214 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Tumores Malignos do Intestino DelgadoTumores do DelgadoCâncer do Intestino DelgadoIntestinal TumoursCancer of the Small BowelPrimary malignant tumours of the small intestine are uncommon and are often diagnosed at na advanced stage. Seventeen cases of malignant tumours of the small intestine were encountered over a 27-year period in the Serviço de Cirurgia from Ribeirão Preto. The ileum was the most common location, with a decreasing frequency proximally. Synchronous tumours were found in 35.29% of the patients. Presenting signs and symptoms were vague and related mainly to abdominal pain (94.12%), nausea and vomiting (52.94%), weight loss (52.94%), and anorexia (35.29%). An abdominal tumour was evident in 35.29910 of patients. Three patients presented with perforation of the tumour, one of them af ter radiotherapy. Barium contrast examination was the primary complementary diagnostic modality. The treatment was wide resection of bowel and mesentery, whenever possible, for jejunal and ileal tumours, together with resection of other involved organs. In one case only biopsy could be perforrned. Lymphoma was the most common malignancy, followed by leiomyosarcoma and adenocarcinoma. The operative mortality was 23.53% (4 patients), 3 from sepsis (two opera ted on with peritonitis) and one from anesthetic problem. Adjuvant radiotherapy and/or chemotherapy was used in the patients who survived surgery except in one. AlI leiomyosarcoma recurred and the patients were opera ted on again with a new resection. Four patients are alive from 2 to 15 years af ter surgery The 5-year survival rate for the lymphomas is 25% (38% if the operative deaths are excluded), and for the adenocarcinoma is 100% (only 2 cases). Whereas the symptoms are vague, the diagnostic of small bowel tumour must be cogitated if the prognosis is to be improved.Os tumores malignos primários do intestino delgado são raros e freqüentemente diagnosticados em estádios avançados. Num período de 27 anos (1960-1987) foram atendidos no Serviço de Cirurgia de Ribeirão Preto, 17 pacientes com neoplasia maligna de delgado. A maior parte das lesões se assestavam no ileo, com freqüência decrescente a montante. Havia tumores sincrônicos em 35,29% dos casos. Os sinais e sintomas clínicos mais freqüentes foram: dor abdominal (94,12%), náuseas e vômitos (52,94%), perda de peso (52,94%) e anorexia (35,29%). Por ocasião do primeiro atendimento, 3 pacientes tinham peritonite por perfuração do tumor, uma delas subseqüente à radioterapia. Dos exames complementares, o de maior valor foi o estudo radiológico contrastado do delgado. O tratamento consistiu na ressecção do segmento comprometido e do mesentério, incluindo outros órgãos eventualmente envolvidos. Em um caso, apenas a biópsia pôde ser realizada. O tipo histológico mais freqüente foi o linfoma, seguido pelo leiomiossarcoma eadenocarcinoma. Tivemos a lamentar 4 óbitos operatórios (23,53%), 3 por choque séptico (2 operados na vigência de peritonite e 1 por deiscência de anastomose) e 1 por acidente anestésico. Foi empregada a quimio e/ou radioterapia adjuvante em todos os pacientes que sobreviveram o pós-operatóno, à exceção de um paciente que se negou a recebê-los. Todos os 3 pacientes com leiomiossarcoma apresentaram recidiva e foram reoperados. Quatro pacientes estavam vivos por ocasião do último seguimento, com sobrevida entre 2 e 15 anos. A sobrevida de 5 anos foi de 25% para os linfomas (38% quando excluídos os óbitos operatórios) e de 100% para os adenocarcinomas, embora se trate de apenas 2 casos. Desde que os sinais e sintomas nos tumores de delgado são vagos e mal definidos, é necessário que esse diagnóstico seja cogitado para que o diagnóstico mais precoce seja estabelecido e conseqüentemente se tenha um melhor prognóstico.INCA2023-08-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/321410.32635/2176-9745.RBC.1987v33n3.3214Revista Brasileira de Cancerologia; Vol. 33 No. 3 (1987): Sept.; 235-240Revista Brasileira de Cancerologia; Vol. 33 Núm. 3 (1987): sept.; 235-240Revista Brasileira de Cancerologia; v. 33 n. 3 (1987): set.; 235-2402176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/3214/2073https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessZiliotto Júnior, AntonioMendes, José Antonio MansurKunzle, Johann EugenDelphini Júnior, Ovídio2023-08-03T20:44:22Zoai:rbc.inca.gov.br:article/3214Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-08-03T20:44:22Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Tumores Malignos do Intestino Delgado |
title |
Tumores Malignos do Intestino Delgado |
spellingShingle |
Tumores Malignos do Intestino Delgado Ziliotto Júnior, Antonio Tumores do Delgado Câncer do Intestino Delgado Intestinal Tumours Cancer of the Small Bowel |
title_short |
Tumores Malignos do Intestino Delgado |
title_full |
Tumores Malignos do Intestino Delgado |
title_fullStr |
Tumores Malignos do Intestino Delgado |
title_full_unstemmed |
Tumores Malignos do Intestino Delgado |
title_sort |
Tumores Malignos do Intestino Delgado |
author |
Ziliotto Júnior, Antonio |
author_facet |
Ziliotto Júnior, Antonio Mendes, José Antonio Mansur Kunzle, Johann Eugen Delphini Júnior, Ovídio |
author_role |
author |
author2 |
Mendes, José Antonio Mansur Kunzle, Johann Eugen Delphini Júnior, Ovídio |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Ziliotto Júnior, Antonio Mendes, José Antonio Mansur Kunzle, Johann Eugen Delphini Júnior, Ovídio |
dc.subject.por.fl_str_mv |
Tumores do Delgado Câncer do Intestino Delgado Intestinal Tumours Cancer of the Small Bowel |
topic |
Tumores do Delgado Câncer do Intestino Delgado Intestinal Tumours Cancer of the Small Bowel |
description |
Primary malignant tumours of the small intestine are uncommon and are often diagnosed at na advanced stage. Seventeen cases of malignant tumours of the small intestine were encountered over a 27-year period in the Serviço de Cirurgia from Ribeirão Preto. The ileum was the most common location, with a decreasing frequency proximally. Synchronous tumours were found in 35.29% of the patients. Presenting signs and symptoms were vague and related mainly to abdominal pain (94.12%), nausea and vomiting (52.94%), weight loss (52.94%), and anorexia (35.29%). An abdominal tumour was evident in 35.29910 of patients. Three patients presented with perforation of the tumour, one of them af ter radiotherapy. Barium contrast examination was the primary complementary diagnostic modality. The treatment was wide resection of bowel and mesentery, whenever possible, for jejunal and ileal tumours, together with resection of other involved organs. In one case only biopsy could be perforrned. Lymphoma was the most common malignancy, followed by leiomyosarcoma and adenocarcinoma. The operative mortality was 23.53% (4 patients), 3 from sepsis (two opera ted on with peritonitis) and one from anesthetic problem. Adjuvant radiotherapy and/or chemotherapy was used in the patients who survived surgery except in one. AlI leiomyosarcoma recurred and the patients were opera ted on again with a new resection. Four patients are alive from 2 to 15 years af ter surgery The 5-year survival rate for the lymphomas is 25% (38% if the operative deaths are excluded), and for the adenocarcinoma is 100% (only 2 cases). Whereas the symptoms are vague, the diagnostic of small bowel tumour must be cogitated if the prognosis is to be improved. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-08-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3214 10.32635/2176-9745.RBC.1987v33n3.3214 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/3214 |
identifier_str_mv |
10.32635/2176-9745.RBC.1987v33n3.3214 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3214/2073 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 33 No. 3 (1987): Sept.; 235-240 Revista Brasileira de Cancerologia; Vol. 33 Núm. 3 (1987): sept.; 235-240 Revista Brasileira de Cancerologia; v. 33 n. 3 (1987): set.; 235-240 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042234786316288 |